Organogenesis Holdings
ORGO
131 hedge funds and large institutions have $114M invested in Organogenesis Holdings in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 38 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 41
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.09% less ownership
Funds ownership: 42.76% → 40.66% (-2.1%)
13% less funds holding
Funds holding: 150 → 131 (-19)
24% less capital invested
Capital invested by funds: $149M → $114M (-$35.4M)
45% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 38
92% less call options, than puts
Call options by funds: $28K | Put options by funds: $345K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.15M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.64M |
| 3 |
D.E. Shaw & Co
New York
|
+$2.25M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.14M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$2.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$16.3M |
| 2 |
Morgan Stanley
New York
|
-$3.59M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.98M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.73M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.47M |
ORGO Hedge Fund Activity: Q1 2023 in Review
131 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2023, worth a combined $114M — down 24% from $149M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of ORGO and 21 opened new positions — a net loss of 17 holders — while 41 trimmed existing stakes and 49 added.
The largest buyer was Soleus Capital Management, adding an estimated $6.15M. The largest seller was BlackRock, cutting an estimated $16.3M.
- 131 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2023, down from 150 in Q4 2022.
- Funds reported $114M of Organogenesis Holdings stock for Q1 2023, down 24% quarter-over-quarter.
- 21 funds opened new Organogenesis Holdings positions in Q1 2023 and 38 closed out, a net change of -17 holders.
- The largest Organogenesis Holdings buyer in Q1 2023 was Soleus Capital Management, an estimated $6.15M added.
- The largest Organogenesis Holdings seller in Q1 2023 was BlackRock, an estimated $16.3M sold.
Based on aggregated 13F filings for Q1 2023.